Document is current
Any future updates will be listed below
-
Authors
Chong, Marvin Y. https://orcid.org/0000-0002-4179-6290
Frenken, Koen G.
Eussen, Simone J. P. M.
Koster, Annemarie
Pot, Gerda K.
Breukink, Stéphanie O.
Janssen-Heijnen, Maryska
Keulen, Eric T. P.
Bijnens, Wouter
Buffart, Laurien M.
Meijer, Kenneth
Scheer, Frank A. J. L.
Steindorf, Karen
de Vos-Geelen, Judith
Weijenberg, Matty P.
van Roekel, Eline H.
Bours, Martijn J. L.
- License Information
-
More Information
Article History
Received: 24 January 2024
Accepted: 24 April 2024
First Online: 2 May 2024
Declarations
:
: This study was conducted according to the guidelines laid down in the Declaration of Helsinki and all procedures involving human subjects/patients were approved by the Medical Ethics Committee of the University Hospital Maastricht and Maastricht University (METC 11–3-075 | NL38786.068.11.). All patients provided written informed consent prior to participation.
: Not applicable.
: Judith de Vos-Geelen has served as a consultant for Amgen, AstraZeneca, MSD, Pierre Fabre, and Servier, and has received institutional research funding from Servier, all outside the submitted work. F.A.J.L. Scheer served on the Board of Directors for the Sleep Research Society and has received consulting fees from the University of Alabama at Birmingham and Morehouse School of Medicine. F.A.J.L. Scheer interests were reviewed and managed by Brigham and Women’s Hospital and Partners HealthCare in accordance with their conflict of interest policies. F.A.J.L.S. consultancies are not related to the current work. The other authors declare that they have no competing interests.
